Potency assay development uses DoE and QbD to improve accuracy, consistency, and regulatory readiness in biologics testing.
May 4, 2026 Drugs designed to clear amyloid beta from the brain—once seen as a promising path to slowing Alzheimer’s—may not actually help patients in any meaningful way, according to a major review ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results